|Bid||6.940 x 800|
|Ask||6.950 x 4000|
|Day's Range||6.89 - 7.15|
|52 Week Range||4.05 - 12.52|
|Beta (3Y Monthly)||2.29|
|PE Ratio (TTM)||32.20|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CannTrust stock will begin trading on the New York Stock Exchange on Monday, joining other Canadian marijuana stocks that listed on U.S. exchanges.
HENDERSON, NV / ACCESSWIRE / February 22, 2019 / Cannabis stocks are roaring back in 2019, producers are reporting record outputs and investors are seeing great returns. As the market continues to blossom, ...
Nearly every day, headlines are popping up surrounding these innovative companies in the healthcare industry as they tackle the prevalent need for qualitative care. Whereas other industries may have different core values and purposes, healthcare companies are tasked with keeping consumers healthy and amid that responsibility, if done correctly, lies the potential for lucrative opportunities. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Zosano Pharma Corporation (ZSAN), Achieve Life Sciences Inc (ACHV), and Aurora Cannabis Inc (ACB) represent four healthcare companies focused on the advancement of the global healthcare industry.
Cannabis News Alimentation Couche-Tard (TSX: ATD.A) (TSX: ATD.B) has signed a deal with Canopy Growth (TSX: WEED) (NYSE: CGC) to launch a premium cannabis retail brand in London, Ontario. Located at 1025 Wellington Road in London, the licensed Tweed store is expected to open in April. Canadians for Fair Access to Medical Marijuana (CFAMM), a […]The post Cannabis Stock News Daily Roundup February 22 appeared first on Market Exclusive.
Aurora Cannabis (NYSE:ACB) has pulled back in recent days. ACB stock sold off on a mildly disappointing earnings report and the reshuffling of its board of directors. Furthermore, it faces concerns as many of its peers have moved into the U.S. hemp market ahead of them. However, given production increases and the likelihood of entering the U.S. market soon, I expect Aurora stock to move higher in the near term.Source: Shutterstock By just about any measure, ACB stock appears expensive. The equity trades at over 56 times sales. Its forward P/E ratio also exceeds 300. Its saving grace is that the other three Canadian cannabis companies among the top four -- Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY), and Cronos (NASDAQ:CRON) -- see similarly outsized financial metrics. These stocks also cratered after marijuana gained official legal status in Canada. Fortunately for ACB and its peers, the pre-legalization hype returns as the U.S. moves toward nationwide legalization. The Farm Bill signed late last year legalized industrial hemp. This is the segue Canadian companies have begun to use to enter the U.S. market. As more states adopt medical and recreational weed, both the legalization and the stock price hype continue to build. Concerns Remain for ACB StockAdmittedly, investors who have become paranoid from too much recreational weed use can find reasons to panic. The Q2 earnings report became a slight disappointment due to excise taxes and lowered net pricing. Moreover, Tilray's decision to purchase Manitoba Harvest makes it the largest Canadian player in the U.S. hemp industry. This has caused some concern as Aurora has not yet moved into the U.S. hemp market.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * The 10 Best Cheap Stocks to Buy Right Now Changes in its board of directors may also cause concern. However, this was mostly current board members shifting positions on the board. Chairman of the board Michael Singer is now executive chairman. This will involve Mr. Singer more in the firm's day-to-day operations.Still, all this news led to a muted reaction. ACB stock price fell from the mid-$7 per share range to around $7 per share. While I do not think I would classify this as a "buying opportunity," I also do not see any of this news as a reason to sell ACB stock. The new board arrangement could help the company. Moreover, given Canopy's and Tilray's moves into the U.S. hemp market, Aurora will probably follow suit soon.Moreover, Aurora increased production by 502% on a year-over-year basis, higher than Canopy's 334% increase. Canopy still produced 10,102 kg in the prior quarter, higher than Aurora's 6,999 kg. Still, production increases continue as legal weed remains in short supply.A bigger question for investors likely involves not whether ACB stock will rise, but whether it will outperform its peers. Although I expect Aurora stock to perform well, it is not my favorite in the sector. In this industry, I recommend one of two things. I would either choose Canopy or Tilray as they are the top two stocks. Or, I would go with a relative value play such as HEXO (NYSEAMERICAN:HEXO) or CannTrust (NYSE:CTST). Their comparatively low P/E ratios make them possible buyout candidates. If that does not happen, they could catch up to larger peers on valuation over time. The Bottom Line on ACB StockNonetheless, Aurora should move higher soon due to production increases and a likely move into the new U.S. hemp market. Yes, earnings slightly disappointed investors. And the lack of an announcement on U.S. hemp may also concern some investors. Even if a CGC or a TLRY become a better buy, I see ACB stock moving higher.Yes, it is expensive, but so are most of its peers. Legal cannabis remains in short supply, and Aurora continues to increase production. Also, assuming it wants to remain among the four largest cannabis stocks, one can safely assume that plans are underway to enter the U.S. hemp market. * 7 Healthy Dividend Stocks to Buy for Extra Stability For these reasons, I do not think stockholders should worry about whether Aurora will rise. I think the bigger question involves whether ACB will perform better than its peers? Only time can answer that question.As of this writing, Will Healy is long CTST stock. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Smart Money Stocks to Buy Now * The 10 Best Cheap Stocks to Buy Right Now * 7 Restaurant Stocks to Watch in 2019 Compare Brokers The post Can Aurora Cannabis Stock Get as High as Its Peers? appeared first on InvestorPlace.
Tilray's deal to acquire the hemp food maker Manitoba Harvest has bolstered the outlook of the already high-flying marijuana ETF.
The company said Darren Karasiuk will be promoted to chief commercial officer. Karasiuk previously occupied the position of executive vice president of adult usage, global. Jill Swainson was promoted from senior vice president of legal affairs to chief legal officer and corporate secretary.
The cannabis industry, however, is one of the nation's most energy intensive, often demanding 24-hour indoor lighting rigs, heating, ventilation and air-conditioning systems at multiplying grow sites. Legal cannabis cultivation in the U.S. consumes an estimated 1.1 terawatt-hours of electricity a year, according to the 2018 Cannabis Energy Report, published by Scale Microgrid Solutions along with New Frontier Data and the Resource Innovation Institute. The Company has developed a microgrid power solution for the cannabis industry cuts the monthly electricity bill of indoor grow-houses by up to 82%.
CALGARY , Feb. 21, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (CSE:HITI) (2LY.F), an Alberta -based downstream cannabis corporation focused on the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has been licensed to open its ninth Canna Cabana retail store, which is located at #105, 330 10th Street NW in Calgary, Alberta (the "Kensington Store"). The Kensington Store has been converted from a Smoker's Corner location and is now the first franchised Canna Cabana outlet in the High Tide network.
If all of this attention surrounding the cannabis sector continues at its current rate, this may result in an influx of investors looking to the marijuana stock market for opportunities. Nabis Holdings (INNPF) (NAB), HEXO Corp (HEXO), New Age Beverages Corporation (NBEV), and Aurora Cannabis Inc (ACB) are four cannabis companies heating up on Wednesday. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.
Tilray's acquisition of the world's largest hemp food company could give the Canadian marijuana producer an edge over its top rivals.
Welcome to the second installment of “Bulls and Bud,” where we take a look at some of the most promising stocks and brands in the legal cannabis industry. Margins Matter Aurora Cannabis (NYSE: ACB ) and ...
For the uninitiated, an executive chair has a more active role in the day-to-day operations of a company. Aurora named independent director Ronald Funk as a lead independent director and Margaret Atkins as a new independent director and chair of the audit committee.
The fact is that the marijuana industry is still very much in its infancy because, until recently, society had historically been vehemently opposed to cannabis. If this continues, the cannabis industry may see an increase in investor attention in the near future. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Village Farms International Inc (VFFIF), CannTrust Holdings Inc (OTC PINK: CNTTF), and Aurora Cannabis Inc (NYSE: ACB, TSX: ACB) are four pot stocks that could test this week's highs.
HENDERSON, NV / ACCESSWIRE / February 20, 2019 / Cannabis stocks were mixed on Tuesday, amid a flurry of announcements on the progress of medical and recreational-use bills around the U.S. Pennsylvania's ...
Aurora Cannabis Inc. said Wednesday it appointed Michael Singer, who was previously chairman of the board, as executive chairman. It also named Ronald Funk lead independent director and Margaret Atkins as new independent director and chair of the audit committee. Diane Jang, who had been on the board since November 2017, has resigned her position as director. "As Aurora continues to mature into one of the world's largest and leading cannabis companies, it is important that our board continues to examine its composition to ensure that its experience and expertise aligns with the company's strategic direction," Singer said. Aurora's stock, which was still inactive in premarket trade, has rallied 15% over the past three months, while the ETFMG Alternative Harvest ETF has hiked up 23% and the S&P 500 has gained 5.2%.
WKN: A1C4WM) announced today that Michael Singer , previously Chairman of the Board, has been appointed Executive Chairman of the Board of Directors. The Company also announced that independent director Ronald Funk has been named Lead Independent Director and Margaret ("Sha n") Atkins has been appointed as a new independent director and Chair of the Audit Committee.
Canadian marijuana producer Canopy Growth might not have enough weed stocked up to keep its grip on nearly a third of the nation's legal cannabis market, GMP Securities said.
On a regular basis I make notes on all the stocks I've been trading. This allows me to stay focused on my overall thesis and to have a clear plan of action. I generally will have 50 or more names.
The cannabis space remains enticing thanks to both the short-term and long-term trends we have in place. As a result of those trends, it has become a natural interest among investors. Attention has been gravitating toward Canopy Growth (NYSE:CGC) and not because it's the wildest one to trade. Instead, it's because CGC stock is one of the more high-quality names in the industry.Should it be one you consider on the long side?As with everything in the stock market, it comes down to several considerations. Things like, what kind of timeline are investors using, what is their risk tolerance and do they consider themselves traders or investors?InvestorPlace - Stock Market News, Stock Advice & Trading TipsNot only do the answers to these questions indicate whether investors should be in the cannabis space at all, but it also impacts whether Canopy stock is their best choice. For instance, if they are investors instead of traders, they may be best suited in a name like Cronos Group (NASDAQ:CRON) or CGC stock. If they're traders, perhaps Tilray (NASDAQ:TLRY) or Aurora Cannabis (NYSE:ACB) may be better suited for their tastes.That's not to say ACB can't be an investment or CGC a trade, but it's all about putting the most odds in our favor. So how exactly does Canopy Growth benefit long-term investors looking for alpha in the cannabis trade?Let's explore. Valuing Canopy Growth StockAt first, investors were cheering the company's earnings results. Canopy Growth stock initially jumped about 4% despite missing earnings expectations and buyers were holding up the stock. However, selling pressure has since set in and it tells me that the share price needs time to digest. * 10 Smart Money Stocks to Buy Now Last quarter, revenue of $83 million (Canadian dollars, by the way) surged more than 282% vs. the same quarter a year ago. Canopy Growth stock recorded a GAAP loss of 38 cents per share, missing estimates for a loss of 25 cents per share by 13 cents. Losses aside, the company is absolutely crushing it. Triple-digit revenue growth is Canopy's "short-term" driver, while long-term investors remain optimistic about further legalization.In the U.S., only about 20% of the country has approved cannabis for recreational consumption. While it will take time to achieve a full 100%, the country continues to gravitate in that direction, as well as making progress on the federal level. Let's not also forget whole countries -- like Canada -- can approve cannabis use for its population, too.This long-term legalization catalyst is one reason the highly regarded Constellation Brands (NYSE:STZ) dumped $4 billion into CGC to own roughly 40% of the company. Still, its valuation looms large. Shares command a market cap of roughly $16 billion. Even if the company racked up $400 million in sales this year, we're still talking about a price-to-sales ratio of 40.Whew, that's high. But if CGC can maintain a lofty level of revenue growth, the company will eventually grow into that valuation. It will take patience and nerves of steel for investors to participate in that migration, but the long-term payoff could be huge. CGC Stock ChartsIn the last section, I talked about the need for CGC stock to digest. It's not so much the earnings result that stretched out Canopy, but the entire move over the last two months. The stock essentially doubled from its December lows to its January highs. * 7 Financial Stocks With Accelerating Growth Any time a stock does that, a pullback or consolidation is justified. One major observation I have on CGC stock is its inability to take out its January high when it released earnings last week. In other words, despite investors seemingly liking the quarter, they didn't like it enough to bid it up to new 2019 highs. It also shows some downtrend pressure from the stock's earlier run in the fourth quarter of 2018.Overall though, the trend is up. Despite this, I think CGC stock is now a buy-on-any-dip candidate. I would like to see a drop into the mid-$30s and for the 50-day and/or 200-day moving average to support the name. That would allow Canopy Growth stock to digest the big move without negating its uptrend.Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Hot Stocks Leading the Market's Blitz Higher * 7 Strong Buy Stocks With Over 20% Upside * 5 Growthy Stocks Trading Below 15X Earnings Compare Brokers The post Is Canopy Growth Stock the Best Cannabis Play? appeared first on InvestorPlace.